Company / Shareholders' Equity
PULSE BIOSCIENCES, INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$80.7M
FY2025
5-year range
-$2.2M / $114.9M
FY2021-FY2025
Trend
-29.8%
vs FY2024
Sector context
#147 of 161
Health Care
What the data says
Among 161 Health Care companies, PULSE BIOSCIENCES, INC. is in the bottom 9% for shareholders' equity. Shareholders' Equity has fluctuated over the past 10 years, ranging from -$2M in FY2022 to $115M in FY2024.
Based on SEC 10-K filings.
$81M in FY2025 with a 5-year CAGR of +28.6%.
Improved from $36M to $81M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +28.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 161This company $80.7M Sector average $5.1B
▼
-98.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +28.6%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 29.8% year-over-year.
- Ranks #147 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $80.7M | -29.8% |
| FY2024 | $114.9M | +221.8% |
| FY2023 | $35.7M | +1687.6% |
| FY2022 | -$2.2M | -106.3% |
| FY2021 | $35.7M | +55.9% |
| FY2020 | $22.9M | -25.5% |
| FY2019 | $30.7M | -53.7% |
| FY2018 | $66.3M | +44.2% |
| FY2017 | $46.0M | +81.8% |
| FY2016 | $25.3M | +85.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026